论文部分内容阅读
目的:观察合贝爽与心律平转复室上性心动过速(PSVT)的临床疗效分析。方法:选择80例室上性心动过速的患者,随机分成两组,每组40例,观察组予合贝爽5~20 mg,5 min静脉推注,对照组予心律平70 mg,5 min静脉推注,观察转复成功率,复律时间与不良反应。结果:PSVT转复成功率合贝爽组为85%,心律平组为70%;平均复律时间合贝爽组为5.06 min,心律平组为10.05 min;不良反应发生率合贝爽组为5%,心律平组为7.5%。结论:合贝爽转复室上性心动过速效果良好,可以作为PSVT急诊治疗的常规药物之一。
Objective: To observe the clinical curative effect of HBSR and PSRT. Methods: Eighty patients with supraventricular tachycardia were randomly divided into two groups (n = 40 in each group). The observation group received 5 ~ min intravenous injection to observe the success rate of recovery, cardioversion time and adverse reactions. Results: The success rate of PSVT was 95% in Beibei Shuang group and 70% in Belling Shuangpai group, 5.06 minutes in Beipu Shuang group and 10.05 minutes in Beipu Shuang group, and the incidence of adverse reactions was 5%, heart rate group 7.5%. CONCLUSION: Combine with Shuangshuang has good effect on the recovery of supraventricular tachycardia, and it can be used as one of the routine drugs in emergency treatment of PSVT.